CAP weighs in on U.S. Senate's FDA user fee authorization bill

By LabPulse.com staff writers

May 18, 2022 -- The College of American Pathologists (CAP) has released remarks regarding the draft U.S. Food and Drug Administration (FDA) user fee authorization bill released by the Senate Health, Education, Labor, and Pensions (HELP) Committee.

The bill would mandate greater regulatory oversight of laboratory-developed tests (LDTs) and includes sections of the Verifying Accurate Leading-edge IVCT Development (VALID) Act, the CAP said.

"We are reviewing the most recent draft of the legislation for the oversight of laboratory-developed tests," CAP president Dr. Emily Volk said in a statement released by the college. "The CAP looks forward to continued engagement with the Senate HELP Committee to advocate for improvements to address the concerns pathologists have had over prior versions of the VALID Act."

CAP names diversity, equity, and inclusion director
The College of American Pathologists (CAP) has appointed a new diversity, equity, and inclusion (DEI) director. Terri Dickinson-Creasey will work with...
CAP calls for action to reduce health disparities
To mark National Minority Health Month this April, the College of American Pathologists (CAP) is urging Congress to act on proposed legislation that addresses...
New CAP guideline addresses diffuse glioma management
A new guideline published by the College of American Pathologists (CAP) aims to improve how patients with diffuse glioma, a common type of primary brain...
CAP welcomes new president and doles out awards
The College of American Pathologists (CAP) appointed new leadership and presented awards at this year's annual meeting, being held September 25-28 in...
CAP supports mandatory COVID-19 vaccination
The College of American Pathologists (CAP) has issued an announcement urging healthcare workers to get COVID-19 vaccines. The group also said it supports...

Copyright © 2022 LabPulse.com

Last Updated bc 5/19/2022 6:34:47 AM